Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 859, pseudogene (RNU6-859P) is a non-coding genomic sequence listed in gene annotation databases as a pseudogene related to U6 small nuclear RNA (snRNA), specifically the 859th annotated U6 pseudogene in humans[2]. Pseudogenes are DNA sequences that resemble functional genes but have lost their protein-coding ability or are otherwise non-functional, often due to mutations or genomic rearrangement[4][6]. The U6 snRNA itself is a highly conserved RNA component essential for splicing as part of the spliceosome complex, but pseudogenes derived from U6 such as RNU6-859P do not code for functional RNA, are not incorporated into the spliceosome, and have no known biological activity[1][3][5]. Consequently, RNU6-859P is *not* considered a therapeutic target and does not have associated biological functions, disease roles, drug interactions, or safety concerns. Due to its non-functional and non-protein-coding nature, "RNA, U6 small nuclear 859, pseudogene" is not a valid drug target; if entered as a therapeutic target, this entry would be considered incorrect for that purpose[2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 859, pseudogene (RNU6-859P).